The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Naeem, Mariam
    Pharmacist born in September 1996
    Individual (3 offsprings)
    Officer
    2022-11-21 ~ now
    OF - director → CIF 0
    Miss Mariam Naeem
    Born in September 1996
    Individual (3 offsprings)
    Person with significant control
    2022-11-21 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

MARIAM N PHARMA LTD

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Par Value of Share
Class 1 ordinary share
12023-12-01 ~ 2024-11-30
Property, Plant & Equipment
35,191 GBP2024-11-30
Cash at bank and in hand
528 GBP2024-11-30
47,057 GBP2023-11-30
Creditors
Current
21,968 GBP2024-11-30
25,692 GBP2023-11-30
Net Current Assets/Liabilities
-21,440 GBP2024-11-30
21,365 GBP2023-11-30
Total Assets Less Current Liabilities
13,751 GBP2024-11-30
21,365 GBP2023-11-30
Creditors
Non-current
11,667 GBP2024-11-30
Net Assets/Liabilities
2,084 GBP2024-11-30
21,365 GBP2023-11-30
Equity
Called up share capital
1 GBP2024-11-30
1 GBP2023-11-30
Retained earnings (accumulated losses)
2,083 GBP2024-11-30
21,364 GBP2023-11-30
Equity
2,084 GBP2024-11-30
21,365 GBP2023-11-30
Average Number of Employees
22023-12-01 ~ 2024-11-30
12022-11-21 ~ 2023-11-30
Property, Plant & Equipment - Gross Cost
Motor vehicles
43,989 GBP2024-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles
8,798 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
8,798 GBP2024-11-30
Property, Plant & Equipment
Motor vehicles
35,191 GBP2024-11-30
Bank Borrowings/Overdrafts
Current
5,000 GBP2024-11-30
Corporation Tax Payable
Current
7,449 GBP2024-11-30
13,082 GBP2023-11-30
Other Taxation & Social Security Payable
Current
75 GBP2024-11-30
Accrued Liabilities
Current
936 GBP2024-11-30
900 GBP2023-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2024-11-30
Profit/Loss
Retained earnings (accumulated losses)
8,719 GBP2023-12-01 ~ 2024-11-30
Dividends Paid
Retained earnings (accumulated losses)
-28,000 GBP2023-12-01 ~ 2024-11-30

  • MARIAM N PHARMA LTD
    Info
    Registered number SC751031
    340 Kings Park Avenue, Rutherglen, Glasgow G73 2AG
    Private Limited Company incorporated on 2022-11-21 (2 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-20
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.